Navigation Links
Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study

By Amanda Gardner
HealthDay Reporter

TUESDAY, Feb. 8 (HealthDay News) -- Removing many lymph nodes may not be necessary in women with early breast cancer who also undergo a lumpectomy to remove the mass, followed by radiation.

Researchers reporting in the Feb. 9 issue of the Journal of the American Medical Association found that just removing one or two sentinel nodes -- those lymph nodes to which the cancer spreads first -- allows women to live just as long as women who have more lymph nodes removed from under their arm.

But it's unclear at this point whether this could be practice-changing.

"If you're looking at a woman with a very limited amount of disease in the sentinel node and with a very limited amount of disease undergoing breast conservation surgery [lumpectomy], it may suggest that they can potentially avoid axillary dissection [removing most or all of the lymph nodes under the arm] . . . but that's being said with a lot of caution," noted Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City, who was not involved with the study. "[But] we can't say that they absolutely can."

Another expert was more emphatic.

"This is an important study," said Dr. Jay Brooks, chairman of hematology and oncology at Ochsner Health System in Baton Rouge, La. "It's the largest randomized trial showing that women with positive sentinel nodes do not necessarily need to have further axillary [underarm] sampling when treated with radiation and/or chemo. This will reduce complications, and will change the way doctors approach patients."

Among other things, removal of lymph nodes can result in a painful and debilitating condition called lymphedema, or swelling, because lymph fluids can no longer travel freely through the body.

The standard of care in breast cancer is still debated but generally, said Bernik, "If you have a positive lymph node, the standard generally is to use axillary dissection unless [cancer involvement] is thought to be minimal in the lymph node."

These researchers, from the John Wayne Cancer Institute at Saint John's Health Center in Santa Monica, Calif., wanted to see if they could avoid axillary dissection without compromising survival.

After undergoing lumpectomy to remove the tumor, followed by radiation and chemotherapy, women with evidence of cancer in one or two sentinel nodes were randomized to undergo axillary node dissection of 10 nodes or, alternatively, to forgo any further treatment.

The study involved about 1,000 women, only half of the 2,000 the researchers had set out to enroll.

In those having axillary node dissection, the median number of nodes removed was 17, vs. two with sentinel only.

But there didn't seem to be any differences with survival, with more than 92 percent in both groups still alive after five years, indicating to the authors that sentinel node biopsy might be not only less invasive, with fewer side effects, but also effective.

But the report is unlikely to quell an ongoing controversy surrounding lymph node removal, Bernik said. In fact, she noted, it may even add to it.

The women in the study were not necessarily representative of all women with breast cancer, and generally had less cancer in their lymph nodes: Those with cancer that had progressed further were unlikely to be willing to be randomized into one of the two groups, she said.

"People have to understand that we're looking not at all women undergoing sentinel node biopsy. We're looking at a select group," Bernik said. "Some people are going to say that based on this data, we can avoid axillary dissection, and I think it's probably too premature to say that."

More information

The U.S. National Cancer Institute has more on sentinel lymph node biopsy.

SOURCES: Stephanie Bernik, M.D., chief, surgical oncology, Lenox Hill Hospital, New York City; Jay Brooks, M.D., chairman, hematology and oncology, Ochsner Health System, Baton Rouge, La.; Feb. 9, 2011 Journal of the American Medical Association

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Removing Gallbladder Sooner Cuts Costs, Readmissions
2. Removing 2mm around breast cancer tumors prevents residual disease in 98 percent of patients
3. New Finding Suggests Safe Surgical Margins When Removing Breast Cancers
4. Sleep Study May Be Advisable Before Removing Tonsils, Adenoids
5. Tumors hide out from the immune system by mimicking lymph nodes
6. Specific lymph node radiotherapy is well tolerated after surgery in early breast cancer patients
7. New class of drug kills lymphoma cells
8. Routine breast cancer biopsy might predict lymph node cancer spread
9. Vitamin K may protect against developing non-Hodgkins lymphoma, say Mayo Clinic researchers
10. The Cancer Help Store Debuts New Blog with Information About Lymphedema and Cancer
11. Scott & White Healthcare clinical trials target lymphoma, leukemia
Post Your Comments:
Related Image:
Removing Many Lymph Nodes in Early Breast Cancer Not Always Needed: Study
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: